Culp, Inc. (NYSE:CULP – Get Free Report) Director Jonathan Lee Kelly purchased 5,200 shares of Culp stock in a transaction that occurred on Monday, July 22nd. The stock was bought at an average cost of $5.36 per share, with a total value of $27,872.00. Following the completion of the transaction, the director now owns 48,571 shares of the company’s stock, valued at $260,340.56. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.
Culp Stock Performance
NYSE CULP opened at $5.13 on Friday. The firm has a market cap of $63.97 million, a PE ratio of -4.62 and a beta of 1.22. Culp, Inc. has a one year low of $4.25 and a one year high of $5.99. The firm’s fifty day moving average is $4.62 and its two-hundred day moving average is $4.75.
Culp (NYSE:CULP – Get Free Report) last posted its quarterly earnings data on Friday, June 28th. The textile maker reported ($0.39) EPS for the quarter, beating analysts’ consensus estimates of ($0.44) by $0.05. The company had revenue of $49.53 million for the quarter, compared to analyst estimates of $49.76 million. Culp had a negative net margin of 6.13% and a negative return on equity of 16.42%. During the same period in the previous year, the business posted ($0.38) earnings per share. Research analysts predict that Culp, Inc. will post -0.03 earnings per share for the current year.
Institutional Inflows and Outflows
Analyst Upgrades and Downgrades
Separately, StockNews.com initiated coverage on shares of Culp in a research note on Thursday. They issued a “hold” rating on the stock.
Get Our Latest Stock Report on Culp
About Culp
Culp, Inc manufactures, sources, markets, and sells mattress fabrics, sewn covers, and cut and sewn kits for use in mattresses, foundations, and other bedding products in the United States, North America, the Far East, Asia, and internationally. It operates in two segments, Mattress Fabrics and Upholstery Fabrics.
See Also
- Five stocks we like better than Culp
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Viking Therapeutics: Pharma Stock Soars on Positive Earnings
- Comparing and Trading High PE Ratio Stocks
- Top 3 Small Cap Stocks Emerging as Rotation Winners
- About the Markup Calculator
- Bargain Alert: 3 Stocks Worth Watching While The Market Cools
Receive News & Ratings for Culp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Culp and related companies with MarketBeat.com's FREE daily email newsletter.